Loading organizations...
Oriza Seed Capital (Oriza Yuandian) is a venture capital firm founded in 2013 and based in Suzhou, China. The firm operates as an investment entity focused on supporting early-stage companies. It functions as a subsidiary of Oriza Holdings, aligning its investment strategies within the parent organization's broader financial objectives.
The firm's investment approach includes participation in various funding rounds, with evidence suggesting a distinct strategy regarding lead investments, where its activity is 22 percentage points less than the average. Oriza Seed Capital has invested in companies such as PackGene Biotech and ClinChoice, and has been identified as an investor in the wellness startup sector in China. Its team includes professionals like investment director Zhang Wei, contributing to its operational capacity.
Oriza Seed Capital (Oriza Yuandian) operates as a subsidiary of Oriza Holdings, integrating its investment activities within the parent company's broader financial framework.
Oriza Seed Capital (Oriza Yuandian) works on 22 percentage points less than the average amount of lead investments compared to other organizations.
Oriza Seed Capital has been identified as an active investor in the wellness startup sector in China, and has invested in companies like PackGene Biotech and ClinChoice.
Oriza Seed Capital (Oriza Yuandian) operates as a subsidiary of Oriza Holdings, integrating its investment activities within the parent company's broader financial framework.
Oriza Seed Capital (Oriza Yuandian) works on 22 percentage points less than the average amount of lead investments compared to other organizations.
Oriza Seed Capital has been identified as an active investor in the wellness startup sector in China, and has invested in companies like PackGene Biotech and ClinChoice.
Oriza Seed Capital (Oriza Yuandian) is a venture capital firm established in 2013, headquartered in Suzhou, China. The firm operates as an investment entity within the venture ecosystem, primarily focusing on early-stage companies. It is recognized as a subsidiary of Oriza Holdings, integrating its investment activities within the larger organizational structure.
The firm employs a distinct investment strategy, particularly concerning its engagement in lead investments. Reports indicate that Oriza Seed Capital's involvement in lead investments is 22 percentage points less than the average for comparable organizations. This suggests a preference for co-investing or participating in rounds led by other entities, or a specific niche in its funding approach.
Oriza Seed Capital has built a portfolio that includes companies such as PackGene Biotech and ClinChoice. Its investment scope extends to various sectors, with a notable presence in the wellness startup landscape in China. The firm has been listed among the top wellness startup investors in the region, reflecting its active participation in this specific industry.
Operationally, Oriza Seed Capital maintains a team of professionals to manage its investment activities. As of available data, the firm has several employee profiles, including an investment director, Zhang Wei. These personnel contribute to the firm's due diligence processes, portfolio management, and strategic decision-making.
The firm's participation in significant funding rounds, such as a $100,000,000 Series A round, underscores its capacity to deploy substantial capital. Oriza Seed Capital continues to be an active participant in the Chinese venture capital market, contributing to the funding and growth of innovative enterprises across its targeted sectors.
Oriza Seed Capital (Oriza Yuandian) has 1 tracked investment across 1 company. The latest tracked deal is $43.4M Series D in AOSSCI in February 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 10, 2026 | AOSSCI | $43.4M Series D | Yibin NEW Energy | Chengdu Jiaozi Financial Holding, Chengdu Science And Technology Venture Capital, CICC Capital, Dongwu Capital, Jiaxin ZHI, Leili Investment |